001067.KS

JW Pharmaceutical Corporation [001067.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

001067.KS Stock Summary

Top 001067.KS Correlated Resources

001067.KS


Top 10 Correlated ETFs

001067.KS


Top 10 Correlated Stocks

001067.KS


001067.KS Financial details

Company Rating
Strong Buy
Market Cap
1399.31B
Income
12.13B
Revenue
660.66B
Book val./share
8068.37
Cash/share
-
Dividend
325
Dividend %
0.51%
Employees
1.11K
Optionable
No
Shortable
Yes
Earnings
-
P/E
139.84
Forward P/E
-
PEG
-10.18
P/S
2.57
P/B
7.92
P/C
-
P/FCF
45.61
Quick Ratio
-
Current Ratio
1.22
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
376.47
EPS next Y
-
EPS next Q
-
EPS this Y
-95.82%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.04%
Revenue last 5Y
3.82%
Revenue Q/Q
2.93%
EPS Q/Q
744.09%
-
-
-
-
SMA20
-4.28%
SMA50
-13.43%
SMA100
-11.88%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
6%
ROC
0.16%
Gross Margin
40%
Oper. Margin
7%
Profit Margin
2%
Payout
71%
Shs Outstand
21.9M
Shs Float
11.51M
-
-
-
-
Target Price
-
52W Range
54800.0-75800.0
52W High
-15.7%
52W Low
+16.61%
RSI
52
Rel Volume
0.03
Avg Volume
144
Volume
4
Perf Week
3.57%
Perf Month
-4.05%
Perf Quarter
-12.1%
Perf Half Y
-11.13%
-
-
-
-
Beta
0.330332
-
-
Volatility
623.03%, 1555.87%
Prev Close
-0.31%
Price
63900
Change
-0.31%

001067.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
33.19K35.46K33.75K36.13K26.32K
Net income per share
-49531.77-1.67K-1.01K-42
Operating cash flow per share
2.21K3.44K3.67K4.16K786.49
Free cash flow per share
1.49K2.89K2.8K3.17K226.63
Cash per share
2.12K2.04K2.76K3.65K2.85K
Book value per share
17.87K17.17K15.19K13.69K8.73K
Tangible book value per share
16.54K16.17K13.77K12.53K7.25K
Share holders equity per share
17.87K17.17K15.19K13.69K8.73K
Interest debt per share
13.15K12.14K13.12K12.53K10.96K
Market cap
618.38B649.8B602.67B801.68B1368.82B
Enterprise value
776.64B794.07B748.33B973.45B1580.59B
P/E ratio
-832.8680.65-23.84-52.6-1.41K
Price to sales ratio
1.231.211.181.462.26
POCF ratio
18.4912.4710.8512.7175.53
PFCF ratio
27.4814.8514.216.7262.1
P/B Ratio
2.282.52.623.866.8
PTB ratio
2.282.52.623.866.8
EV to sales
1.541.481.461.782.61
Enterprise value over EBITDA
29.5121.69-276.3764.4535.56
EV to operating cash flow
23.2215.2413.4815.4487.21
EV to free cash flow
34.5218.1417.6320.27302.66
Earnings yield
00.01-0.04-0.020
Free cash flow yield
0.040.070.070.060
Debt to equity
0.050.180.140.360.61
Debt to assets
0.570.560.60.620.7
Net debt to EBITDA
6.013.94-53.811.374.76
Current ratio
1.51.641.211.281.3
Interest coverage
2.452.48-1.69-0.174.25
Income quality
-45.056.47-2.2-4.14-18.73
Dividend Yield
0.010.010.010.010.01
Payout ratio
-7.930.81-0.27-0.46-7.39
Sales general and administrative to revenue
0.120.120.080.120.14
Research and developement to revenue
0.040.040.050.040.03
Intangibles to total assets
0.030.030.040.030.03
Capex to operating cash flow
-0.33-0.16-0.24-0.24-0.71
Capex to revenue
-0.02-0.02-0.03-0.03-0.02
Capex to depreciation
-0.58-0.47-0.64-0.73-0.8
Stock based compensation to revenue
00000
Graham number
4.44K14.33K23.87K17.61K2.87K
ROIC
0.060.06-0.0600.09
Return on tangible assets
00.01-0.05-0.030
Graham Net
-18.13K-16.64K-16.9K-15.56K-14.22K
Working capital
136.83B145.54B57.07B64.58B83.77B
Tangible asset value
250.64B244.97B208.7B189.8B167.07B
Net current asset value
51.27B40.23B-8.06B-42.29B-78.06B
Invested capital
0.70.670.820.881.22
Average receivables
00000
Average payables
53.74B46.17B46.49B47.89B49.76B
Average inventory
103.91B101.28B95.82B101.2B101.86B
Days sales outstanding
00000
Days payables outstanding
69.247.7146.9947.2650.64
Days of inventory on hand
123.83108.7894.2699.88100.54
Receivables turnover
00000
Payables turnover
5.277.657.777.727.21
Inventory turnover
2.953.363.873.653.63
ROE
00.03-0.11-0.070
Capex per share
-722.79-550.79-864.39-992.61-559.87

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
9.83K1.61K1.49K6.22K6.4K
Net income per share
335.98-63.9391.0937312.32
Operating cash flow per share
1.49K124.5854.89347.12687.38
Free cash flow per share
1.28K84.6518.8262.89556.95
Cash per share
4.57K624.11659.842.63K0
Book value per share
13.63K1.91K1.93K7.72K8.07K
Tangible book value per share
12.4K1.59K1.62K6.47K7.58K
Share holders equity per share
13.63K1.91K1.93K7.72K8.07K
Interest debt per share
14.22K2.36K2.42K9.26K21.35
Market cap
823.74B6365.57B7270.43B1911.37B1667.14B
Enterprise value
1010.26B6577.35B7489.06B2120.47B1667.14B
P/E ratio
40.46-236.58189.65486.4950.27
Price to sales ratio
5.5337.5646.511.589.82
POCF ratio
36.51485.641.26K207.4291.36
PFCF ratio
42.61714.73.68K273.87112.76
P/B Ratio
3.9931.6435.759.337.78
PTB ratio
3.9931.6435.759.337.78
EV to sales
6.7838.8147.912.859.82
Enterprise value over EBITDA
79.78423.03420.03155.71136.77
EV to operating cash flow
44.78501.81.3K230.1191.36
EV to free cash flow
52.26738.473.79K303.84112.76
Earnings yield
0.010000
Free cash flow yield
0.020000.01
Debt to equity
0.490.610.750.740
Debt to assets
0.650.70.70.690.68
Net debt to EBITDA
14.7313.6212.2615.350
Current ratio
1.431.31.461.521.22
Interest coverage
4.574.435.643.3920.39
Income quality
4.43-1.950.69.382.2
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.120.160.140.140.34
Research and developement to revenue
0.040.030.040.040
Intangibles to total assets
0.030.030.030.030
Capex to operating cash flow
-0.14-0.32-0.66-0.24-0.19
Capex to revenue
-0.02-0.02-0.02-0.01-0.02
Capex to depreciation
-0.81-1.04-0.81-0.56-0.85
Stock based compensation to revenue
00000
Graham number
10.15K1.66K1.99K2.54K7.53K
ROIC
0.020.030.030.020.04
Return on tangible assets
0.01-0.010.0200.01
Graham Net
-17.24K-3.11K-3.06K-11.56K-15.93K
Working capital
105.57B83.77B117.4B124.64B74.31B
Tangible asset value
187.89B167.07B170.23B171.8B0
Net current asset value
-32B-78.06B-74.59B-68.51B-7.71B
Invested capital
1.041.221.241.190
Average receivables
00000
Average payables
54.81B55.13B56.49B58.61B0
Average inventory
110.73B107.01B109.29B111.48B0
Days sales outstanding
00000
Days payables outstanding
48.4444.7353.1452.840
Days of inventory on hand
104.4588.8104.7100.510
Receivables turnover
00000
Payables turnover
1.862.011.691.70
Inventory turnover
0.861.010.860.90
ROE
0.02-0.030.0500.04
Capex per share
-213.12-39.93-36.09-84.22-130.43

001067.KS Frequently Asked Questions

What is JW Pharmaceutical Corporation stock symbol ?

JW Pharmaceutical Corporation is a US stock and trading under the symbol 001067.KS

What is JW Pharmaceutical Corporation stock quote today ?

JW Pharmaceutical Corporation stock price is $63900 today.

Is JW Pharmaceutical Corporation stock public?

Yes, JW Pharmaceutical Corporation is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap